Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Fate Therapeutics (FATE) Amortizatization of Intangibles (2016 - 2025)

Fate Therapeutics (FATE) has disclosed Amortizatization of Intangibles for 13 consecutive years, with $881000.0 as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Amortizatization of Intangibles fell 42.42% year-over-year to $881000.0, compared with a TTM value of $3.6 million through Dec 2025, down 60.29%, and an annual FY2025 reading of $3.6 million, down 60.29% over the prior year.
  • Amortizatization of Intangibles was $881000.0 for Q4 2025 at Fate Therapeutics, up from $810000.0 in the prior quarter.
  • Across five years, Amortizatization of Intangibles topped out at $3.3 million in Q3 2023 and bottomed at -$1.5 million in Q2 2021.
  • Average Amortizatization of Intangibles over 5 years is $963650.0, with a median of $974500.0 recorded in 2025.
  • The sharpest move saw Amortizatization of Intangibles plummeted 502.83% in 2021, then skyrocketed 696.33% in 2023.
  • Year by year, Amortizatization of Intangibles stood at -$1.1 million in 2021, then soared by 216.14% to $1.2 million in 2022, then soared by 133.41% to $2.9 million in 2023, then plummeted by 47.35% to $1.5 million in 2024, then crashed by 42.42% to $881000.0 in 2025.
  • Business Quant data shows Amortizatization of Intangibles for FATE at $881000.0 in Q4 2025, $810000.0 in Q3 2025, and $847000.0 in Q2 2025.